Related Experiment Video
Updated: May 7, 2026

Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine
Published on: February 9, 2016
Increased plasma endothelin levels in angina patients with rapid coronary artery disease progression
E G Zouridakis1, R Schwartzman, X Garcia-Moll
1Coronary Artery Disease Research Unit, Cardiological Sciences, St. George's Hospital Medical School, London, U.K.
Insights
Elevated plasma endothelin levels are linked to faster coronary artery disease progression in patients with stable angina. Higher endothelin may indicate an increased risk of rapid stenosis development.
Area of Science:
- Cardiovascular Medicine
- Endocrinology
- Biomarkers
Background:
- Coronary artery disease (CAD) progression is a significant clinical concern.
- Identifying reliable markers for predicting rapid CAD progression is crucial for patient management.
Purpose of the Study:
- To investigate the association between plasma endothelin levels and the rate of coronary artery disease progression.
- To determine if endothelin serves as a predictive marker for rapid stenosis development in patients with stable angina.
Main Methods:
- Quantitative angiography was used to assess changes in coronary stenosis diameter over time.
- Plasma endothelin levels were measured using radioimmunoassay in patients with chronic stable angina.
- Patients underwent two angiographic assessments, with the second performed just before planned coronary angioplasty.
Main Results:
- Rapid coronary artery disease progression was observed in 31.5% of patients.
- Patients with rapid progression had significantly higher baseline plasma endothelin levels compared to those without progression (5.7 vs. 3.9 pg/mL, P<0.001).
- Elevated endothelin was an independent predictor of disease progression, with levels above 4.26 pg/mL associated with a sixfold increased risk.
Conclusions:
- Plasma endothelin levels are elevated in patients experiencing coronary artery disease progression.
- Increased endothelin may serve as a valuable risk marker for rapid stenosis progression.
- Endothelin might play a direct role in the pathogenesis of coronary artery disease progression.
Aims:
To investigate the association between plasma endothelin levels and rapid coronary artery disease progression, as assessed by quantitative angiography.
Methods And Results:
Changes in diameter were assessed in 224 coronary stenoses of 92 consecutive patients (62 men) with chronic stable angina pectoris who were on a waiting list for routine coronary angioplasty and underwent coronary angiography on two occasions: the first (diagnostic) angiogram was carried out at study entry and the second 5.5+/-3.0 months later, immediately prior to coronary angioplasty. A digital quantitative angiographic analysis system was used to assess differences in stenosis diameter between the first and second angiogram. Plasma immunoreactive endothelin levels were estimated by radioimmunoassay at study entry. Rapid coronary artery disease progression occurred in 29 (31.5%) patients according to pre-established criteria: 12 (41%) had a > or =10% diameter reduction of at least one pre-existing stenosis > or =50%, 10 (34%) had a > or =30% diameter reduction of a pre-existing stenosis <50%, 5 (17%) patients developed a new stenosis and 2 (7%) had progression of a lesion to total occlusion by the second angiogram. Baseline demographic, clinical and angiographic data were similar in patients with and without stenosis progression. Plasma endothelin levels were significantly higher in patients with rapid disease progression than in those without (5.7+/-2.0 pg. ml(-1)vs 3.9+/-1.6 pg. ml(-1), P<0.001). Multiple logistic regression analysis revealed that endothelin was an independent predictor of disease progression (P=0.001). Moreover, endothelin levels above 4.26 pg. ml(-1)(the median of the total endothelin concentrations) were associated with a sixfold increase in the risk of developing rapid stenosis progression.
Conclusions:
Plasma endothelin is raised in patients with coronary artery disease progression and may be a marker of risk of rapid stenosis progression. Endothelin may also play a pathogenic role in this process.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Coronary Artery Disease II: Pathophysiology
Acute Coronary Syndrome I: Introduction
Angina I: Introduction
Angina II: Classification
Angina III: Clinical Manifestations and Assessment

